CVS lifts 2026 outlook after quarterly revenue rises 5.4%
The healthcare company reported higher third-quarter adjusted earnings and raised its profit and cash flow targets for the full year.
Makkler Newsroom · Nov 4, 08:41 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $108.46 (+21.4%)
Prices may be delayed and are for informational purposes only - not investment advice.
The healthcare company reported higher third-quarter adjusted earnings and raised its profit and cash flow targets for the full year.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.